Risk factors
Hib bacteria are carried in the nose and throat without showing any signs of infection. Hib is spread through coughing, sneezing or close contact with an infected person. Before the Hib vaccine was introduced, about four in every 100 pre-school children carried the Hib organism; after the vaccine was introduced, carriage rates fell below the level of detection. [4] Hib infections are uncommon in patients older than 6 years. However, the frequency of Hib infections is increased in patients with asplenia, splenectomy, sickle cell disease, malignancies and congenital or acquired immunodeficiencies.
Presentation [1] The most common presentation (60% of all cases) of invasive Hib disease is meningitis, frequently accompanied by bacteraemia. Hib meningitis primarily affects children younger than 2 years, with a peak frequency rate occurring in infants aged 6-9 months. 15% of cases present with epiglottitis. Epiglottitis most commonly occurs in children aged 2-7 years but can also occur in adults. Bacteraemia without any other concomitant infection occurs in 10% of cases. The remainder is made up of cases of septic arthritis, osteomyelitis, cellulitis, pneumonia and pericarditis. Hib pneumonia typically occurs in children aged 4 months to 4 years. Hib causes septic arthritis and cellulitis in children younger than 2 years. Hib septic arthritis also occurs in adults. Neonatal infection:
Often due to non-typeable H. influenzae, which colonises the maternal genital tract. Infection is associated with premature birth, premature rupture of membranes, low birth weight and maternal chorioamnionitis. Presentations include meningitis, pneumonia, respiratory distress, scalp abscess, conjunctivitis and vesicular eruption.
Investigations [5] Gram stain: small, Gram-negative, pleomorphic coccobacilli with polymorphonuclear cells. Bacterial or other relevant body fluid cultures. Slide agglutination with type-specific antisera is used for serotyping H. influenzae. Detection of the polyribosyl ribitol phosphate (PRP) polysaccharide capsule: methods include countercurrent immunoelectrophoresis and enzyme-linked immunosorbent assay; important for providing a rapid diagnosis and is not affected by prior antibiotics. [6] Cerebrospinal fluid (CSF) features in meningitis: pleocytosis with a predominance of neutrophils, decreased CSF glucose levels, increased CSF protein, detectable capsular antigen in 90% and a positive CSF Gram stain result in 80%. CT scan: may be required, particularly to identify a possible subdural effusion, in patients with meningitis, to exclude raised intracranial pressure, if there are focal neurological findings or failure of expected improvement with appropriate antibiotics. CXR: Hib pneumonia tends to cause more pleural and pericardial involvement compared with other bacterial pneumonias. Community-acquired pneumonias due to non-typeable H. influenzae are characterised by alveolar infiltrates in patchy or lobar distributions. Other investigations will depend on the site of infection -eg, echocardiogram if pericarditis is suspected, joint aspiration for septic arthritis.
Management [7] Management includes treating all aspects of the infection, including fever, dehydration and any other specific interventions such as oxygen therapy in respiratory tract infections. Recommendations for antibiotic treatment include:
H. influenzae epiglottitis: intravenous cefotaxime or chloramphenicol. Exacerbations of chronic bronchitis (treat if there is increased sputum production, purulent sputum or dyspnoea): treat for five days (longer in severely ill patients) with amoxicillin, tetracycline or clarithromycin; some H. influenzae strains are tetracyclineresistant and 20% of H. influenzae strains are resistant to amoxicillin. Meningitis: cefotaxime -treat for at least 10 days; use chloramphenicol instead if there is a history of anaphylaxis to penicillin or to cephalosporins or if the organism is resistant to cefotaxime; dexamethasone may also be required; give rifampicin for four days before hospital discharge.
